PERE
FONTOVA PALE
Investigador ata 2023
Universitat de Barcelona
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Universitat de Barcelona (21)
2024
2023
-
A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction
Kidney International, Vol. 104, Núm. 4, pp. 840-850
-
Antimetastatic Properties of Prodigiosin and the BH3-Mimetic Obatoclax (GX15-070) in Melanoma
Pharmaceutics, Vol. 15, Núm. 1
-
CYP3A5*3 and CYP3A4*22 Cluster Polymorphism Effects on LCP-Tac Tacrolimus Exposure: Population Pharmacokinetic Approach
Pharmaceutics, Vol. 15, Núm. 12
-
Cytotoxicity of osmium(ii) and cycloosmated half-sandwich complexes from 1-pyrenyl-containing phosphane ligands
Dalton Transactions, Vol. 52, Núm. 24, pp. 8391-8401
-
Small molecule anion carriers facilitate lactate transport in model liposomes and cells
iScience, Vol. 26, Núm. 10
-
Steric hindrance, ligand ejection and associated photocytotoxic properties of ruthenium(II) polypyridyl complexes
Journal of Biological Inorganic Chemistry, Vol. 28, Núm. 4, pp. 403-420
-
The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations
Pharmaceutics, Vol. 15, Núm. 5
2022
-
A Novel Late-Stage Autophagy Inhibitor That Efficiently Targets Lysosomes Inducing Potent Cytotoxic and Sensitizing Effects in Lung Cancer
Cancers, Vol. 14, Núm. 14
-
Dual Costimulatory and Coinhibitory Targeting with a Hybrid Fusion Protein as an Immunomodulatory Therapy in Lupus Nephritis Mice Models
International journal of molecular sciences, Vol. 23, Núm. 15
-
Tacrolimus CYP3A Single-Nucleotide Polymorphisms and Preformed T- and B-Cell Alloimmune Memory Improve Current Pretransplant Rejection-Risk Stratification in Kidney Transplantation
Frontiers in Immunology, Vol. 13
2021
-
Dual and opposite costimulatory targeting with a novel human fusion recombinant protein effectively prevents renal warm ischemia reperfusion injury and allograft rejection in murine models
International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-19
-
Influence of the Circadian Timing System on Tacrolimus Pharmacokinetics and Pharmacodynamics After Kidney Transplantation
Frontiers in Pharmacology, Vol. 12
-
Mycophenolic acid interferes the transcriptional regulation and protein trafficking of maturation surface markers in dendritic cells
International Immunopharmacology, Vol. 91
-
Sustained Inhibition of Calcineurin Activity With a Melt-Dose Once-daily Tacrolimus Formulation in Renal Transplant Recipients
Clinical Pharmacology and Therapeutics, Vol. 110, Núm. 1, pp. 238-247
-
Tp53-induced glycolysis and apoptosis regulator (TIGAR) is upregulated in lymphocytes stimulated with concanavalin A
International Journal of Molecular Sciences, Vol. 22, Núm. 14
2020
-
Validation and evaluation of four sample preparation methods for the quantification of intracellular tacrolimus in peripheral blood mononuclear cells by UHPLC-MS/MS
Clinica Chimica Acta, Vol. 503, pp. 210-217
2018
-
Evaluation of linezolid or trimethoprim/sulfamethoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of staphylococcal biofilm
International Journal of Antimicrobial Agents, Vol. 51, Núm. 6, pp. 854-861
-
PI3K–Akt signaling controls PFKFB3 expression during human T-lymphocyte activation
Molecular and Cellular Biochemistry, Vol. 448, Núm. 1-2, pp. 187-197
2017
-
TGF-β1 targets Smad, p38 MAPK, and PI3K/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells
FEBS Journal, Vol. 284, Núm. 20, pp. 3437-3454